When Law, Ethics & Medicine Collide: Considering Medical Aid in Dying


University of Minnesota Consortium in Law and Values in Health, Environment and the Life Sciences




Tag(s): Past

Consortium Webinar Explores Debate Over Physician Aid in Dying
The Consortium on Law and Values in Health, Environment & the Life Sciences is hosting a virtual Lecture Series titled “When Law, Ethics & Medicine Collide.” The first webinar in the series, “Considering Medical Aid in Dying,” will be Wed., May 1, from Noon to 1:30pm Central time. Registration is free.
Ten states and the District of Columbia currently have statutes on the books or a court decision that authorizes medical aid in dying (often called MAID) for adults who are terminally ill. Many additional states, including Minnesota, are debating similar legislation. First legalized in 1997 under the Oregon Death with Dignity Act, these state statutes authorize doctors to prescribe lethal medication that the patient may choose to take. No U.S. state statute authorizes euthanasia.
In 2016, Canada authorized both provision of a lethal prescription and euthanasia. Starting in 2027, Canada plans to enlarge eligibility to patients whose only underlying condition is a mental illness. Canada has faced significant pushback from human rights advocates and disability rights organizations, suggesting the nation’s legal framework lacks the necessary oversight and safeguards to protect vulnerable populations.
The webinar will feature three international experts on the law, ethics, and clinical realities of medical aid in dying, both in the U.S. and Canada — Thaddeus Mason Pope, JD, PhD (Mitchell Hamline School of Law); K. Sonu Giand, MD (University of Toronto); and Nancy Berlinger, PhD (The Hastings Center). They will bring different perspectives and disciplines to this important debate.

Event start time: 12:00 pm

Event end time: 01:30 am

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Privacy Policy. By closing this message, you are consenting to our use of cookies.